T. Reed Stephens
Partner
Co-Chair, Health Care and Life Sciences Industry Group
Reed is a nationally recognized legal authority in the life sciences industry, as well as the pharmaceutical fraud and abuse and corporate compliance spaces, and focuses his practice on fraud and abuse defense, corporate compliance, and risk management across the full spectrum of healthcare providers, managed care organizations, pharmaceutical manufacturers and medical device companies. He has extensive experience with the Anti-Kickback Statute and Stark Physician Self-Referral Law, and False Claims Act litigation.
Key Matters
Some of the experience represented below may have been handled at a previous firm.
- United States ex rel. Kunz v. Halifax Health, et al. – Obtained summary judgment for defendants on non-intervened False Claims Act allegations involving more than US$450M in alleged damages for Anti-Kickback Statute, Stark law and Medicare lack of medical necessity violations
- United States ex rel. Bates and Patrick v. Kyphon, Inc.– Represented several health systems in the long-running Medicare short stay Kyphoplasty medical necessity False Claims Act qui tam
- United States ex rel. Cortinas v. Midtown Imaging, LLC, et al. – Obtained favorable mediated resolution of False Claims Act Anti-Kickback allegations
- Advised senior management and the board of directors of a global manufacturer in connection with whistleblower allegations of employee misconduct
- Represented a major pharmaceutical manufacturer in a joint U.S. Senate and U.S House of Representatives congressional investigation of pharmaceutical product price increases
- Represented several employees of a pharmaceutical manufacturer during federal grand jury proceedings in an Off Label Promotion civil/criminal investigation
- Represented department head of an academic medical center during a federal criminal investigation of Anti-Kickback allegations against medical device company Olympus
- Obtained declination and dismissal with prejudice of False Claims Act allegations of Medicare false billing assert against a national rehabilitation hospital chain
- Represented a global U.S. defense contractor in connection with a voluntary disclosure to the U.S. Department of Defense of contract billing compliance concerns
- Assisted a pharmaceutical manufacturer in achieving compliance with court-ordered remedial steps involving enhancements to corporate by-laws and regulatory affairs responsibilities triggered by a shareholder derivative case
- Represented U.S. subsidiary of a global gaming company in connection with District of Columbia Office of Attorney General investigation of government contract compliance